Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

Autor: Annese, Vito, Beaugerie, Laurent, Egan, Laurence, Biancone, Livia, Bolling, Claus, Brandts, Christian, Dierickx, Daan, Dummer, Reinhard, Fiorino, Gionata, Gornet, Jean Marc, Higgins, Peter, Katsanos, Konstantinos H., Nissen, Loes, Pellino, Gianluca, Rogler, Gerhard, Scaldaferri, Franco, Szymanska, Edyta, Eliakim, Rami, Bossuyt, P., Bogut, A., Krznaric, Z., Mijandrusic Sincic, B., Bortlik, M., Douda, T., Knudsen, T., Manninen, P., Nieminen, U., Kucharzik, T., Siegmund, B., Koutroubakis, I., Epameinondas, T., Lakatos, P., Waterman, M., Kohn, A., Goll, Null, Kierkus, J., Zagorowicz, E., Diculescu, M. M., Tarabar, D., Drobne, D., Gisbert, J., Strid, H., Pierik, M., Celik, A. F., Irving, P., Marshall, J., Riis, L., Amiot, A., Mantzaris, G., Sinagra, E., Sampietro, G., D'Incà, R., De Ridder, L., Nunesl, P. B., Marin Jimenez, I., Ramirez, V. H., Juillerat, P., Claridge, A., Macdonald, J., Rieder, F., SELVAGGI, Francesco

Publikováno v: Journal of Crohn's and Colitis, 9, 945-65
Journal of Crohn's and Colitis, 9, 11, pp. 945-65
Annese, Vito; Beaugerie, Laurent; Egan, Laurence; Biancone, Livia; Bolling, Claus; Brandts, Christian; Dierickx, Daan; Dummer, Reinhard; Fiorino, Gionata; Gornet, Jean Marc; Higgins, Peter; Katsanos, Konstantinos H; Nissen, Loes; Pellino, Gianluca; Rogler, Gerhard; Scaldaferri, Franco; Szymanska, Edyta; Eliakim, Rami; Juillerat, Pascal (2015). European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & Colitis, 9(11), pp. 945-965. Oxford University Press 10.1093/ecco-jcc/jjv141

The global prevalence of cancer is increasing, largely as more patients are living into old age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] increasingly are managing patients with cancer, or a previous hi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec600ed7aafd1272e32a946c6fabd68
https://doi.org/10.1093/ecco-jcc/jjv141

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effectiveness of entecavir treatment and predictive factors for virologic response

Autor: Preda, C. M., Cristian Baicus, Negreanu, L., Tugui, L., Olariu, S. V., Andrei, A., Zambatu, I., Diculescu, M. M.

Publikováno v: Europe PubMed Central
Scopus-Elsevier
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 5, Pp 305-311 (2014)
Revista Española de Enfermedades Digestivas v.106 n.5 2014
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

Introduction: Entecavir (ETV) is a potent inhibitor of hepatitis B virus (HBV) replication. In patients adherent to treatment, virologic remission rates of > 95 % can be maintained with entecavir at 3-5 years Aim and methods: A cohort study was perfo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::579bdf6ef878de5a0a23c5eeb19abb0b
http://europepmc.org/abstract/med/25287232